Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ilaria Cetta"'
Autor:
Calogera Butera, Ilaria Cetta, Roberta Messina, Laura Zanandrea, Roberto Santangelo, Bruno Colombo, Massimo Filippi, Ubaldo Del Carro
Publikováno v:
Cephalalgia Reports, Vol 7 (2024)
Since the high burden of chronic migraine (CM), it is challenging to identify the best prevention treatment. Based on the preclinical evidence about the different therapeutic targets of onabotulinumtoxinA (BT-A), acting on C-fibers, and anti-CGRP mon
Externí odkaz:
https://doaj.org/article/81858da2a2d147fe98a7e5b119f72fef
Autor:
Marta Waliszewska-Prosół, Danilo Antonio Montisano, Mariola Antolak, Federico Bighiani, Francescantonio Cammarota, Ilaria Cetta, Michele Corrado, Keiko Ihara, Regina Kartamysheva, Igor Petrušić, Maria Magdalena Pocora, Tsubasa Takizawa, Gloria Vaghi, Paolo Martelletti, Barbara Corso, Alberto Raggi, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background The burden and disability associated with headaches are conceptualized and measured differently at patients’ and populations’ levels. At the patients’ level, through patient-reported outcome measures (PROMs); at population l
Externí odkaz:
https://doaj.org/article/ab3b2972ab244f7287506834fab4b14c
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background The migraine attack is classically divided into the prodromal, aura, headache and postdromal phase. Previous studies have highlighted non-headache symptoms associated with migraine occurring during the prodromal or postdromal phas
Externí odkaz:
https://doaj.org/article/55227677828e44b5af97259fc11a940b
Autor:
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo FilippiBonassi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri, for the FRIEND-Study Group
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Fremanezumab has demonstrated to be effective, safe, and tolerated in the prevention of episodic or chronic migraine (CM) in randomized, placebo-controlled trials (RCTs). Real-life studies are needed to explore drug effects in uns
Externí odkaz:
https://doaj.org/article/177a4ccbfcd447ef960ecb7c1dbd9556
Autor:
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri, for the FRIEND-Study Group
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/e2dcdbe4161b4da8ba14f4558b5ec465
Autor:
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d’Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri, and for the FRIEND-Study Group
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/d8aec07843c54892a6ca4abb29e6ffcf
Autor:
Roberta Messina, Paola Valsasina, Laura Zanandrea, Ilaria Cetta, Bruno Colombo, Maria Rocca, Massimo Filippi
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3c5ae64db78bf05f02daa2f0db06733
https://doi.org/10.1212/wnl.0000000000202384
https://doi.org/10.1212/wnl.0000000000202384
Autor:
Calogera Butera, Ilaria Cetta, Roberta Messina, Laura Zanandrea, Roberto Santangelo, Bruno Colombo, Massimo Filippi, Ubaldo Del Carro
Since the high burden of chronic migraine (CM), it is challenging to identify the best prevention treatment. Based on the preclinical evidences about the different therapeutic targets of OnabotulinumtoxinA (BT-A), acting on C-fibers and anti-CGRP mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c6d9509b28ddf1b8a1e0327aa899952
https://doi.org/10.21203/rs.3.rs-2513021/v1
https://doi.org/10.21203/rs.3.rs-2513021/v1
Autor:
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Florindo d'Onofrio, Maria Albanese, Ilaria Cetta, Paola Di Fiore, Maurizio Zucco, Massimo Filippi, Francesco Bono, Claudia Altamura, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri
Publikováno v:
The journal of headache and pain. 23(1)
Background Fremanezumab has demonstrated to be effective, safe, and tolerated in the prevention of episodic or chronic migraine (CM) in randomized, placebo-controlled trials (RCTs). Real-life studies are needed to explore drug effects in unselected p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf2acc5ca0618224062f09ef00c2558
https://pubmed.ncbi.nlm.nih.gov/35672670
https://pubmed.ncbi.nlm.nih.gov/35672670
Autor:
Francesca Sangalli, Antonino Giordano, Massimo Filippi, Ilaria Cetta, Vittorio Martinelli, Federico Montini, Bruno Colombo, Mario Orrico
Publikováno v:
Neurological Sciences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8a7ac697cbf12fbbbb8c7c173c8588